Nadroparin Almost Halves The Risk Of Developing Blood Clots In Ambulatory Cancer Patients Receiving Chemotherapy
Links shared publicly online about this topic.
- 1,774total visits
Nadroparin Almost Halves The Risk Of Developing Blood Clots In Ambulatory Cancer Patients Receiving Chemotherapy
Nadroparin, a blood-thinning drug, halves the risk of developing blood clots in ambulatory cancer patients receiving chemotherapy, and as such could become an important preventive treatment in the
View full resource at medicalnewstoday.com
Tags: Cancer, Chemotherapy, Thrombotic Event, Blood Clot, Drug
Most Recently Shared on September 4, 2009 at 4:07 am By:
Nadroparin Almost Halves The Risk Of Developing Blood Clots In Ambulatory Cancer Patients Receiving Chemotherapy.. http://bit.ly/10dzZz
Advertisement
